Page 7 - Pharma Industry
Zydus Lifesciences gets USFDA nod for its painkiller Celecoxib capsules
The company said that the medicine is used to treat pain or inflammation caused by many conditions such as arthritis, ankylosing spondylitis, and menstrual pain
 "Zydus Lifesciences gets USFDA nod for its painkiller Celecoxib capsules")
Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales
India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising obesity and growing doctor awareness
 "Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales")
Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp
Sun Pharma will pay Incyte an upfront fee and royalties to market Leqselvi in the US for alopecia areata until patent expiry in FY26 following a litigation settlement
 "Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp")
Wockhardt exits US generics biz, to focus on innovative portfolio
Wockhardt exits the US generics market after years of losses, shifting focus to new antibiotic drug discovery and biologicals, including insulin, to create long-term value.
 "Wockhardt exits US generics biz, to focus on innovative portfolio")
Anthem Biosciences expands manufacturing capacity ahead of ₹3,395-cr IPO
CRDMO firm Anthem Biosciences expands peptide and API production, with Unit 4 under development, as it prepares for a Rs 3,395-crore IPO opening on July 14
 "Anthem Biosciences expands manufacturing capacity ahead of ₹3,395-cr IPO")
Trump threatens 200% pharma, 50% copper tariffs: What it means for India
As trade tensions escalate under Donald Trump, India finds itself in the crosshairs once again. Donald Trump's proposed duties target two of India's biggest export sectors - pharmaceuticals and copper
 "Trump threatens 200% pharma, 50% copper tariffs: What it means for India")
India's pharma exports to US surged in March amid tariff concerns
India's pharma exports saw a significant rise in March, driven by fears of impending US tariffs. Industry experts anticipate impact of potential reciprocal tariffs on India's future export strategy
 "India's pharma exports to US surged in March amid tariff concerns")
GMP, NSQ compliance: MSME pharmaceutical companies seek financial aid
Pharma MSMEs seek Rs 50 crore handholding and extension for GMP compliance under revised Schedule M, citing challenges in adhering to regulatory and quality standards
 "GMP, NSQ compliance: MSME pharmaceutical companies seek financial aid")
HC-ordered expert panel for weight loss drug may be set up by mid-July
A Delhi HC directive to examine unregulated use of weight loss drugs may lead to a CDSCO expert panel by mid-July, possibly led by DCGI with pharma and govt representation
 "HC-ordered expert panel for weight loss drug may be set up by mid-July")
Pharma GCCs tap artificial intelligence to fast-track drug discovery
They are not just cutting down drug development time, but also the cost involved in it. AI is reshaping how drugs and therapies are developed
 "Pharma GCCs tap artificial intelligence to fast-track drug discovery")
Lupin carves out consumer healthcare biz into wholly owned subsidiary
The carve-out will be effective from 1 July 2025, according to the company's regulatory filing on the exchanges.
 "Lupin carves out consumer healthcare biz into wholly owned subsidiary")
KKR's JB Chemicals exit cements its strong healthcare track record
The sale of its 46.39 per cent stake in JB Chemicals to Torrent Pharmaceuticals comes over four years after KKR acquired control of the company in 2020
 "KKR's JB Chemicals exit cements its strong healthcare track record")
Biological E to make HPV9 vaccine under licensing pact with Recbio
BE to produce and commercialise Recbio's nine-valent HPV vaccine in India and global markets, including participation in UNICEF and PAHO tenders
 "Biological E to make HPV9 vaccine under licensing pact with Recbio")
Pharma majors turn to acquisitions as cash stockpile hits ₹49,000 crore
India's top drugmakers are reportedly sitting on their highest cash reserves in at least five years, up over 120% from FY20
 "Pharma majors turn to acquisitions as cash stockpile hits ₹49,000 crore")
Bharat Biotech signs pact with GSK to develop Shigella vaccine candidate
Hyderabad-based Bharat Biotech will lead Phase 3 trials, regulatory progress and manufacturing for Shigella vaccine altSonflex1-2-3 in collaboration with GSK
 "Bharat Biotech signs pact with GSK to develop Shigella vaccine candidate")
NPPA fixes retail prices for 41 drug combinations, including empagliflozin
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments, citing steep price drops and growing generic availability
 "NPPA fixes retail prices for 41 drug combinations, including empagliflozin")
Zydus signs deal with Agenus for BOT and BAL cancer therapies in India
Zydus Lifesciences has partnered with Agenus to license the cancer immunotherapies Botensilimab and Balstilimab for India and Sri Lanka, expanding its oncology offerings
 "Zydus signs deal with Agenus for BOT and BAL cancer therapies in India")
Sun Pharma halts development of SCD-044 drug after trial disappointment
Sun Pharma discontinues work on its experimental skin drug SCD-044 after Phase 2 trial results fall short of goals for treating psoriasis and atopic dermatitis
 "Sun Pharma halts development of SCD-044 drug after trial disappointment")
Medical representatives barred from govt hospitals to stop pharma influence
The Centre's move seeks to curb the influence of pharmaceutical companies. Sharing of information must now happen through email or other digital platforms
 "Medical representatives barred from govt hospitals to stop pharma influence")
Lupin signs licensing deal with SteinCares for ranibizumab in LatAm
Lupin will manufacture biosimilar ranibizumab while SteinCares handles registration and marketing in Latin America, excluding Mexico and Argentina